ACM
MDT icon

Argentus Capital Management’s Medtronic MDT Stock Holding History

Argentus Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-10,344
Closed -$641K – 336
2014
Q3 		$641K Buy
+10,344
New +$658K 0.1% 237
2014
Q1 		– Sell
-16,868
Closed -$968K – 217
2013
Q4 		$968K Buy
16,868
+999
+6% +$56.6K 0.21% 92
2013
Q3 		$845K Buy
15,869
+4,171
+36% +$224K 0.19% 99
2013
Q2 		$602K Buy
+11,698
New +$578K 0.14% 117

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Argentus Capital Management's MDT Position: Q4 2014 in Review

Argentus Capital Management sold out of Medtronic (MDT) in Q4 2014, closing a stake of 10,344 shares — an estimated $641K sold.

Argentus Capital Management first reported a position in MDT in Q2 2013 and held it in 4 quarters. The position peaked at $968K in Q4 2013. 1,154 funds tracked by Wall St. Rank hold MDT as of Q4 2014.

  • Argentus Capital Management reported no remaining Medtronic position as of Q4 2014 after selling out during the quarter.
  • Argentus Capital Management sold 10,344 Medtronic shares in Q4 2014, an estimated $641K.
  • Argentus Capital Management first reported a position in Medtronic in Q2 2013 and held it in 4 quarters.
  • Argentus Capital Management's Medtronic position peaked at $968K in Q4 2013.
  • 1,154 funds tracked by Wall St. Rank held Medtronic as of Q4 2014.

Based on Argentus Capital Management's 13F filing for Q4 2014, filed 12 Jan 2015.